EUVIMEDEUVIMED entdecken
Querschnittstudie

A Cross-Sectional Study on the Management of Amblyopia

Dr. Aishwarya M, Dr. C. Indhu, Dr. K. Namitha Bhuvaneshwari

International Journal of Drug Delivery Technology · 25.04.2026 · 16 (22s)

DOI: 10.25258/ijddt.16.22s.49 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Dr. Aishwarya M und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Amblyopia is a leading cause of preventable visual impairment in children and results from abnormal visual development during early childhood. Early diagnosis and appropriate management are essential to prevent permanent visual loss.

Aim

To evaluate the patterns of amblyopia management and assess factors influencing visual outcomes in a cross-sectional study.

Methods

This cross-sectional observational study was conducted on 90 patients aged 3–15 years diagnosed with amblyopia at Meenakshi Medical College over a period of one year. All patients underwent detailed ophthalmic evaluation including visual acuity assessment, cycloplegic refraction, and ocular examination. Amblyopia was classified into anisometropic, strabismic, deprivation, and mixed types. Treatment modalities included refractive correction, occlusion therapy, atropine penalization, or combination therapy. Visual outcomes and compliance were analyzed.

Results

Anisometropic amblyopia was the most common type (44.4%), followed by strabismic amblyopia (27.8%). Occlusion therapy was the most frequently used treatment modality (50%). A total of 64.4% of patients showed improvement in visual acuity. A statistically significant association was found between treatment compliance and visual improvement (p < 0.001).

Conclusion

Amblyopia is a treatable condition when diagnosed early and managed appropriately. Occlusion therapy remains the mainstay of treatment, and compliance plays a critical role in determining visual outcomes. Early screening and patient education are essential to improve treatment success.

Zitieren

APA

M, D. A., Indhu, D. C., & Bhuvaneshwari, D. K. N. (2026). A Cross-Sectional Study on the Management of Amblyopia. International Journal of Drug Delivery Technology, 16(22s). https://doi.org/10.25258/ijddt.16.22s.49

Vancouver

M DA, Indhu DC, Bhuvaneshwari DKN. A Cross-Sectional Study on the Management of Amblyopia. International Journal of Drug Delivery Technology. 2026;16(22s). doi:10.25258/ijddt.16.22s.49

BibTeX
@article{M2026,
  author = {M, Dr. Aishwarya and Indhu, Dr. C. and Bhuvaneshwari, Dr. K. Namitha},
  title = {A Cross-Sectional Study on the Management of Amblyopia},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {22s},
  doi = {10.25258/ijddt.16.22s.49}
}
Kostenlos starten →